Antimicrobial stewardship programs

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 3916-3920

  Leuthner, Kimberly D ^a   Doern, Gary V ^b  

^a University Medical Center of Southern Nevada   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADMINISTRATIVE PERSONNEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL STEWARDSHIP PROGRAM; ANTIMICROBIAL THERAPY; CLINICAL LABORATORY; CLINICAL PATHWAY; DRUG USE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HOSPITAL PHYSICIAN; HUMAN; MEDICAL INFORMATION SYSTEM; OUTCOME ASSESSMENT; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; ORGANIZATIONAL POLICY;

EID: 84889778432     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01751-13     Document Type: Review

References (15)

1. Dellit TH, Owens RC, McGowan JE, Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. 2007. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 44: 159-177.
2. American Society of Health System Pharmacists. 2010. ASHP statement on the pharmacist's role in antimicrobial stewardship and infection prevention and control. Am. J. Health Syst. Pharm. 67:575-577.
3. Paterson DL. 2006. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin. Infect. Dis. 42: S90-S95.
4. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. 2003. Unnecessary use of antimicrobials in hospitalized patients. Arch. Intern. Med. 163:972-978.
5. Leuthner KD, Greenberg A. 2011. An antimicrobial stewardship program without antibiotic restrictions, abstr K-384. Abstr 51st Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL.
6. Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV. 2003. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J. Clin. Microbiol. 41:495-497.
7. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement, Tables 1, M100-S23. CLSI, Wayne, PA.
8. Sharp SE. 1993. Effective reporting of susceptibility test results. Diagn. Microbiol. Infect. Dis. 16:251-254.
9. Schentag JJ, Ballow CH, Fritz AL, Williams JD, Adelman MH. 1993. Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division and the microbiology laboratory. Diagn. Microbiol. Infect. Dis. 16:255-264.
10. Schifman RB, Pindur A, Bryan JA. 1997. Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy. Arch. Pathol. Lab. Med. 121:1168-1170.
11. Doern GV, Vautour R, Gaudet M, Levy B. 1994. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 32:1757-1762.
12. Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W, Verbrugh HA, Vos MC. 2008. Rapid identification and antimicrobial susceptibility testing to reduce antibiotic use and accelerate pathogen-directed antibiotic use. J. Antimicrob. Chemother. 61: 428-435.
13. Hindler JF, Stelling J. 2007. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Insititute. Clin. Infect. Dis. 44:867-873.
14. Clinical and Laboratory Standards Institute. 2005. Analysis and presentation of cumulative antimicrobial susceptibility test data-second edition; M39-A2. CLSI, Wayne, PA.
15. Bantar C, Alcazar G, Franco D, Salamone F, Vesco E, Oliva ME. 2007. Are laboratory-based antibiograms reliable to guide the selection of empirical antimicrobial treatment in patients with hospital-acquired infections? J. Antimicrob. Chemother. 59:140-143.